Human patient membrane glycoproteins GPII-llla and GPIb-IX represent heterodimer complexes that are known to serve as receptors for platelet cohesion and adhesion to the vessel wall, respectively. GPIIb-IIIa also functions as an activation-dependent fibronectin (Fn) receptor. We have used a polyclonal antibody specific for the beta chain of the fibroblast fibronectin receptor (FR) to immunopurify an activation-independent FR from human platelets. Together with GPIIb-IIIa, this human platelet FR is shown to contribute to normal platelet-adhesion to Fn-coated surfaces. It alone can support the adhesion of thrombasthenic platelets which lack GPIIb-IIIa to the same surfaces. Immunopurified human platelet FR is a heterodimer like the fibroblast FR, composed of platelet glycoproteins previously designated GPIc (alpha chain) and GPIIa (beta chain).
The first aim of this proposal is to undertake a comprehensive investigation of the relative role of GPIc-IIa and GPIIb-IIIa in platelet adhesion to fibronectin and other physiologic surfaces. Accumulated evidence suggests that specific conformational rearrangements within and between glycoprotein complexes are probably required for receptor activation and that GP complexes interact specifically with components of the cytoskeleton. We hypothesize that alterations in the association of these glycoproteins with each other and with the cytoskeleton not only modulate receptor function but are likely operative in the mechanisms whereby these receptors are turned on and off. To address this hypothesis, the second aim of this proposal is to analyze specific glycoprotein interactions using methods that can detect changes in glycoprotein-glycoprotein or glycoprotein- cytoskeleton associations in the intact platelet, and to pursue the development and application of protein-specific electron spin resonance (ESR) probes produced by a method developed in our laboratory. These studies will lead to a better understanding of the mechanisms whereby membrane glycoprotein receptor function is maintained and controlled in human platelets, with general appli- cability to all cell types, and to a better appreciation of qualitative defects in these platelet glycoprotein receptors that lead to impaired hemostasis or uncontrolled thrombosis in vivo.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL032279-06
Application #
3343641
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1984-04-01
Project End
1992-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Bloodcenter of Wisconsin, Inc.
Department
Type
DUNS #
City
Milwaukee
State
WI
Country
United States
Zip Code
53233
Kouns, W C; Steiner, B; Kunicki, T J et al. (1994) Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia. Blood 84:1108-15
Kunicki, T J; Orchekowski, R; Annis, D et al. (1993) Variability of integrin alpha 2 beta 1 activity on human platelets. Blood 82:2693-703
Tomiyama, Y; Tsubakio, T; Piotrowicz, R S et al. (1992) The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Blood 79:2303-12
Tomiyama, Y; Brojer, E; Ruggeri, Z M et al. (1992) A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3. J Biol Chem 267:18085-92
Wencel-Drake, J D; Okita, J R; Annis, D S et al. (1991) Activation of calpain I and hydrolysis of calpain substrates (actin-binding protein, glycoprotein Ib, and talin) are not a function of thrombin-induced platelet aggregation. Arterioscler Thromb 11:882-91
Smith, J W; Ruggeri, Z M; Kunicki, T J et al. (1990) Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites. J Biol Chem 265:12267-71
Okita, J R; Frojmovic, M M; Kristopeit, S et al. (1989) Montreal platelet syndrome: a defect in calcium-activated neutral proteinase (calpain). Blood 74:715-21
Kunicki, T J; Beardsley, D S (1989) The alloimmune thrombocytopenias: neonatal alloimmune thrombocytopenic purpura and post-transfusion purpura. Prog Hemost Thromb 9:203-32
Furihata, K; Hunter, J; Aster, R H et al. (1988) Human anti-PlE1 antibody recognizes epitopes associated with the alpha subunit of platelet glycoprotein Ib. Br J Haematol 68:103-10
Kunicki, T J; Nugent, D J; Staats, S J et al. (1988) The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and is identical to the platelet glycoprotein Ia-IIa complex. J Biol Chem 263:4516-9

Showing the most recent 10 out of 28 publications